Anoje Chukwuemeka, Agu Kenneth Anene, Oladele Edward A, Badru Titilope, Adedokun Oluwasanmi, Oqua Dorothy, Khamofu Hadiza, Adebayo Olufunso, Torpey Kwasi, Chabikuli Otto Nzapfurundi
FHI 360, Plot 1073 J.S Tarka Street, Area 3 Garki Abuja, Abuja, Nigeria.
Howard University Pharmacists and Continuing Education Center, Abuja, Nigeria.
AIDS Behav. 2017 Feb;21(2):386-392. doi: 10.1007/s10461-016-1473-z.
Medication adherence is a major determinant of antiretroviral treatment (ART) success. Promptness in medication refill pick-ups may give an indication of medication adherence. This study determined medication refill adherence among HIV positive patients on ART and its association with treatment outcomes in HIV treatment centers in Nigeria. This retrospective multi-center cohort study involved a review of ART refill records for 3534 HIV-positive patients aged 18-60 years who initiated first-line ART between January 2008 and December 2009 and were on therapy for ≥18 months after ART initiation. Drug refill records of these patients for 10 consecutive refill visits after ART initiation were analyzed. The first ten consecutive refill appointment-keeping rates after ART initiation ranged from 64.3 % to 76.1 % which decreased with successive visits. Altogether, 743 (21.1 %) patients were deemed adherent, meaning they picked up their drugs within 7 days of the drug refill appointment date on at least nine out of ten refill visits. The adherent group of patients had a mean CD4 cells increase of 206 ± 6.1 cells/dl after 12 months of ART compared to 186 ± 7.1 cells/dl reported among the nonadherent group (p = 0.0145). The proportion of patients in the adherent category who showed no OIs after 12 months on ART (81 %) was significantly higher when compared to the proportion in the non-adherent category (23.5 %), (p = 0.008). The multivariate analysis showed that the odds of being adherent was 2-3 times more in patients who had a baseline CD4 count of less than 200 cells/dl compared to those with a baseline CD4 of >350 cells/dl. (AOR 2.43, 95 % CI 1.62-3.66). In addition, for patients with baseline CD4 cell count of 201-350 cells/dl, the odds of being adherent was found to be 1.9 compared to those with baseline CD4 of greater than 350 cells/dl (AOR 1.93, 95 % CI 1.27-2.94). Pharmacy refill data can serve as an adherence measure. Adherence to on-time drug pickup on ≥90 % of refill appointments was associated with a better CD4 count response and a reduction in the presence of opportunistic infections in ART patients after 12 months of treatment.
药物依从性是抗逆转录病毒治疗(ART)成功的主要决定因素。按时取药可能表明药物依从性情况。本研究确定了尼日利亚HIV治疗中心接受ART治疗的HIV阳性患者的药物续方依从性及其与治疗结果的关联。这项回顾性多中心队列研究包括对3534例年龄在18至60岁之间的HIV阳性患者的ART续方记录进行审查,这些患者于2008年1月至2009年12月开始接受一线ART治疗,且在ART开始后接受治疗≥18个月。对这些患者ART开始后连续10次续方就诊的药物续方记录进行了分析。ART开始后前10次连续的预约取药率在64.3%至76.1%之间,且随后续就诊次数而降低。共有743例(21.1%)患者被视为依从,即他们在至少十次续方就诊中的九次在药物续方预约日期的7天内取药。与非依从组报告的186±7.1个细胞/微升相比,依从组患者在接受ART治疗12个月后平均CD4细胞增加了206±6.1个细胞/微升(p = 0.0145)。在接受ART治疗12个月后无机会性感染的依从组患者比例(81%)显著高于非依从组(23.5%)(p = 0.008)。多变量分析显示,与基线CD4计数>350个细胞/微升的患者相比,基线CD4计数低于200个细胞/微升的患者依从的几率高出2至3倍(调整后比值比2.43,95%置信区间1.62 - 3.66)。此外,对于基线CD4细胞计数为201 - 350个细胞/微升的患者,与基线CD4大于350个细胞/微升的患者相比,依从的几率为1.9(调整后比值比1.93,95%置信区间1.27 - 2.94)。药房续方数据可作为一种依从性衡量指标。在12个月的治疗后,在≥90%的续方预约中按时取药与更好的CD4计数反应以及ART患者中机会性感染的减少相关。